Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Una Taylor
AddedMar 31, 2024
UpdatedMay 1, 2026
Una Taylor

Una Taylor

Board Member, Protect Pharmaceutical

Una Taylor's Career

Protect Pharmaceutical
Protect Pharmaceutical

Princeton, NJ, US

Board Member· Board
Rokk3r
Rokk3r

Miami, FL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Una Taylor's Career

Protect Pharmaceutical
Protect Pharmaceutical
Public12006Princeton, NJ, US
Board Member· Board

Leadership at Protect Pharmaceutical

Geoff WilliamsGeoff WilliamsBoard Member
Theodore FaisonTheodore FaisonBoard Member

Similar to Protect Pharmaceutical

NovaDel PharmaNovaDel PharmaBranchburg, NJ, USPharmaceuticalsest. 1982NovaDel PharmaBranchburg, NJ, US · est. 1982

NovaDel Pharma Inc. develops novel drug delivery systems, enhancing speed, safety, and convenience of medication intake.

Public · $14M4
Elite PharmaceuticalsElite PharmaceuticalsNorthvale, NJ, USPharmaceuticalsest. 1996Elite PharmaceuticalsNorthvale, NJ, US · est. 1996

Elite Pharmaceuticals innovates and manufactures controlled-release pharmaceuticals, specializing in pain management.

Public · $7.5M53
Concours PharmaceuticalsConcours PharmaceuticalsTrenton, NJ, USPharmaceuticalsest. 2018Concours PharmaceuticalsTrenton, NJ, US · est. 2018

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

Seed · $2.7M30
PharmaINPharmaINBothell, WA, USDrug Deliveryest. 2001PharmaINBothell, WA, US · est. 2001

PharmaIN, a US-based biopharmaceutical firm, enhances injectable therapeutics via patented PGC™ technology.

Seed · $1.5M18
Rokk3r
Rokk3r
Seed$5M752012Miami, FL, US
Board Member· Board

Leadership at Rokk3r

Brian SanchezBrian SanchezCo-Founder
Nabyl CharaniaNabyl CharaniaBoard Member
Salim IsmailSalim IsmailBoard Member
Charles IrizarryCharles IrizarryCo-Founder
Germán MontoyaGermán MontoyaBoard Member

Similar to Rokk3r

StartXStartXNew York City, NY, USPlatform, Softwareest. 2021StartXNew York City, NY, US · est. 2021

StartX: A digital platform for scaling businesses and attracting investors.

Seed · $1M6
RockhopperRockhopperNew York City, NY, USSaaS Platformest. 2023RockhopperNew York City, NY, US · est. 2023

B2B SaaS platform revolutionizing collaboration and knowledge capture in finance.

Pre-Seed · $120k6
founders.aifounders.aiMountain View, CA, USStartup Platform, Venture Buildingest. 2020founders.aiMountain View, CA, US · est. 2020

Founders.ai: Building, investing in, and enhancing AI-driven companies for global impact.

1
StartupyStartupyMiami, FL, USContent, Curationest. 2021StartupyMiami, FL, US · est. 2021

Startupy: A digital hub curating and interconnecting valuable tech and culture insights.

Pre-Seed · $1M18

Una Taylor's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Una Taylor

Michelle RicoMichelle RicoBoard Member · Proto Script PharmaceuticalKate Yanov BirtchKate Yanov BirtchCo-Founder · LinkapediaRon TotaroRon TotaroCEO · ProtegoNakul PasrichaNakul PasrichaCEO · PharmaSecureNick NorrisNick NorrisCo-Founder · Protekt ProductsAmar KanagarajAmar KanagarajFounder & CEO · Protecto